Tsumura & Co. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
28,118
20,078
18,898
17,184
20,284
19,897
Depreciation, Depletion & Amortization
4,871
5,387
5,059
5,629
6,157
6,362
Other Funds
58
76
91
92
92
6,365
Funds from Operations
20,512
16,036
20,708
16,568
21,087
19,894
Changes in Working Capital
14,604
11,043
3,138
4,497
21
14,444
Net Operating Cash Flow
5,908
4,993
17,570
21,065
21,066
5,450
Capital Expenditures
7,690
9,669
7,735
8,299
10,781
Sale of Fixed Assets & Businesses
29
99
1,200
29
19
Purchase/Sale of Investments
5,911
18
12
1,620
12,542
Net Investing Cash Flow
1,694
10,683
7,461
6,451
23,354
Cash Dividends Paid - Total
4,515
4,515
4,515
4,478
4,404
Issuance/Reduction of Debt, Net
-
15,000
-
-
2,267
Net Financing Cash Flow
4,575
10,408
4,608
9,572
50,305
Net Change in Cash
656
4,925
5,784
4,454
48,411
Free Cash Flow
1,761
4,635
9,895
12,854
10,603
Other Sources
66
8
5
201
4
Change in Capital Stock
2
1
2
5,001
27,212
Exchange Rate Effect
1,017
207
283
588
394
Other Uses
10
1,103
943
3
53

About Tsumura &

View Profile
Address
2-17-11 Akasaka
Tokyo Tokyo 107
Japan
Employees -
Website http://www.tsumura.co.jp
Updated 07/08/2019
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. It manufactures and sells Kampo medicine, a traditional form of medicine in Japan. The company is also involved in the procurement, sorting, production, processing, and storage of botanical raw materials; production and sale of Kampo extract intermediates; and provision of logistics, storage, distribution, and materials handling services.